Biologic modulation in renal regeneration

References

• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379:165–180. doi:10.1016/S0140-6736(11)60178-5.
   PubMed Web of Science ®Google Scholar
• James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375:1296–1309. doi:10.1016/S0140-6736(09)62004-3.
   PubMed Web of Science ®Google Scholar
• Mehta RL, Cerda J, Burdmann EA, et al. International Society of Nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet. 2015;385:2616–2643. doi:10.1016/S0140-6736(15)60126-X.
   PubMed Web of Science ®Google Scholar
• Chawla LS, Eggers PW, Star RA, et al. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371:58–66. doi:10.1056/NEJMra1214243.
   PubMed Web of Science ®Google Scholar
• Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20:223–228. doi:10.1681/ASN.2007080837.
   PubMed Web of Science ®Google Scholar
• Little MH. Regrow or repair: potentialregenerative therapies for the kidney. J Am Soc Nephrol. 2006;17:2390–2401. doi:10.1681/ASN.2006030218.
   PubMed Web of Science ®Google Scholar
• Sagrinati C, Ronconi E, Lazzeri E, et al. Stem-cell approaches for kidney repair: choosing the right cells. Trends Mol Med. 2008;14:277–285. doi:10.1016/j.molmed.2008.05.005.
   PubMed Web of Science ®Google Scholar
• Benigni A, Morigi M, Remuzzi G. Kidney regeneration. Lancet. 2010;375:1310–1317. doi:10.1016/S0140-6736(10)60237-1.
   PubMed Web of Science ®Google Scholar
• Fioretto P, Steffes MW, Sutherland DE, et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med. 1998;339:69–75. doi:10.1056/NEJM199807093390202.
   PubMed Web of Science ®Google Scholar
• Fioretto P, Sutherland DE, Najafian B, et al. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int. 2006;69:907–912. doi:10.1038/sj.ki.5000153.
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Perna A, Benini R, et al. In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia. J Am Soc Nephrol. 1999;10:997–1006.
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Perticucci E, Cravedi P, et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol. 2008;19:1213–1224. doi:10.1681/ASN.2007090970.
   PubMed Web of Science ®Google Scholar
• Ruggenenti P, Brenner BM, Remuzzi G. Remission achieved in chronic nephropathy by a multidrug approach targeted at urinary protein excretion. Nephron. 2001;88:254–259.
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Gagliardini E, Sangalli F, et al. ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int. 2006;69:1124–1130. doi:10.1038/sj.ki.5000060.
   PubMed Web of Science ®Google Scholar
• Boffa JJ, Lu Y, Placier S, et al. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol. 2004;14:1132–1144. doi:10.1097/01.ASN.0000060574.38107.3B.
   Web of Science ®Google Scholar
• Pichaiwong W, Hudkins KL, Wietecha T, et al. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol. 2013;24:1088–1102. doi:10.1681/ASN.2012050445.
   PubMed Web of Science ®Google Scholar
• Ma LJ, Nakamura S, Aldigier JC, et al. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol. 2005;16:966–976. doi:10.1681/ASN.2004060492.
   PubMed Web of Science ®Google Scholar
• Wiggins RC. The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int. 2007;71:1205–1214. doi:10.1038/sj.ki.5002222.
   PubMed Web of Science ®Google Scholar
• Macconi D, Sangalli F, Bonomelli M, et al. Podocyte repopulation contributes to regression of glomerular injury induced by ACE inhibition. Am J Pathol. 2009;174:797–807. doi:10.2353/ajpath.2009.080227.
   PubMed Web of Science ®Google Scholar
• Romagnani P. Toward the identification of a “renopoietic system”? Stem Cells. 2009;27:2247–2253. doi:10.1002/stem.140.
   PubMed Web of Science ®Google Scholar
• Romagnani P, Lasagni L, Remuzzi G. Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol. 2013;9:137–146. doi:10.1038/nrneph.2012.290.
   PubMed Web of Science ®Google Scholar
• Shankland SJ, Smeets B, Pippin JW, et al. The emergence of the glomerular parietal epithelial cell. Nat Rev Nephrol. 2014;10:158–173. doi:10.1038/nrneph.2014.1.
   PubMed Web of Science ®Google Scholar
• Angelotti ML, Ronconi E, Ballerini L, et al. Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells. 2012;30:1714–1725. doi:10.1002/stem.1130.
   PubMed Web of Science ®Google Scholar
• Sagrinati C, Netti GS, Mazzinghi B, et al. Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol. 2006;17:2443–2456. doi:10.1681/ASN.2006010089.
   PubMed Web of Science ®Google Scholar
• Ronconi E, Sagrinati C, Angelotti ML, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol. 2009;20:322–332. doi:10.1681/ASN.2008070709.
   PubMed Web of Science ®Google Scholar
• Appel D, Kershaw DB, Smeets B, et al. Recruitment of podocytes from glomerular parietal epithelial cells. J Am Soc Nephrol. 2009;20:333–343. doi:10.1681/ASN.2008070795.
   PubMed Web of Science ®Google Scholar
• Berger K, Schulte K, Boor P, et al. The regenerative potential of parietal epithelial cells in adult mice. J Am Soc Nephrol. 2014;25:693–705. doi:10.1681/ASN.2013050481.
   PubMed Web of Science ®Google Scholar
• Wanner N, Hartleben B, Herbach N, et al. Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol. 2014;25:707–716. doi:10.1681/ASN.2013050452.
   PubMed Web of Science ®Google Scholar
• Eng DG, Sunseri MW, Kaverina NV, et al. Glomerular parietal epithelial cells contribute to adult podocyte regeneration in experimental focal segmental glomerulosclerosis. Kidney Int. 2015;88:999–1012. doi:10.1038/ki.2015.152.
   PubMed Web of Science ®Google Scholar
• Romagnani P, Remuzzi G. Renal progenitors in non-diabetic and diabetic nephropathies. Trends Endocrinol Metab. 2013;24:13–20. doi:10.1016/j.tem.2012.09.002.
   PubMed Web of Science ®Google Scholar
• Lasagni L, Romagnani P. Glomerular epithelial stem cells: the good, the bad, and the ugly. J Am Soc Nephrol. 2010;21:1612–1619. doi:10.1681/ASN.2009121291.
   PubMed Web of Science ®Google Scholar
• Smeets B, Uhlig S, Fuss A, et al. Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol. 2009;20:2604–2615. doi:10.1681/ASN.2008121233.
   PubMed Web of Science ®Google Scholar
• Smeets B, Kuppe C, Sicking EM, et al. Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol. 2011;22:1262–1274. doi:10.1681/ASN.2010090970.
   PubMed Web of Science ®Google Scholar
• Smeets B, Angelotti ML, Rizzo P, et al. Renal progenitor cells contribute to hyperplastic glomerular lesions of different types of podocytopathies and in crescentic glomerulonephritis. J Am Soc Nephrol. 2009;20:2593–2603. doi:10.1681/ASN.2008121233.
   PubMed Web of Science ®Google Scholar
• Lasagni L, Angelotti ML, Ronconi E, et al. Podocyte regeneration driven by renal progenitors determines glomerular disease remission and can be pharmacologically enhanced. Stem Cell Reports. 2015;5:248–263. doi:10.1016/j.stemcr.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Pippin JW, Sparks MA, Glenn ST, et al. Cells of renin lineage are progenitors of podocytes and parietal epithelial cells in experimental glomerular disease. Am J Pathol. 2013;183:542–557. doi:10.1016/j.ajpath.2013.04.024.
   PubMed Web of Science ®Google Scholar
• Starke C, Betz H, Hickmann L, et al. Renin lineage cells repopulate the glomerular mesangium after injury. J Am Soc Nephrol. 2015;26:48–54. doi:10.1681/ASN.2014030265.
   PubMed Web of Science ®Google Scholar
• Rizzo P, Perico N, Gagliardini E, et al. Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat. Am J Pathol. 2013;183:1769–1778. doi:10.1016/j.ajpath.2013.08.008.
   PubMed Web of Science ®Google Scholar
• Darisipudi MN, Kulkarni OP, Sayyed SG, et al. Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. Am J Pathol. 2011;179:116–124. doi:10.1016/j.ajpath.2011.03.004.
   PubMed Web of Science ®Google Scholar
• Lasagni L, Ballerini L, Angelotti ML, et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells. 2010;28:1674–1685. doi:10.1002/stem.492.
   PubMed Web of Science ®Google Scholar
• Ueno T, Kobayashi N, Nakayama M, et al. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss. Kidney Int. 2013;83:1065–1075. doi:10.1038/ki.2013.48.
   PubMed Web of Science ®Google Scholar
• Grouls S, Iglesias DM, Wentzensen N, et al. Lineage specification of parietal epithelial cells requires β-catenin/Wnt signaling. J Am Soc Nephrol. 2012;23:63–72. doi:10.1681/ASN.2010121257.
   PubMed Web of Science ®Google Scholar
• Wu J, Zheng C, Fan Y, et al. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol. 2014;25:92–104. doi:10.1681/ASN.2012111101.
   PubMed Web of Science ®Google Scholar
• Kietzmann L, Guhr SS, Meyer TN, et al. MicroRNA-193a regulates the transdifferentiation of human parietal epithelial cells toward a podocyte phenotype. J Am Soc Nephrol. 2015;26:1389–1401. doi:10.1681/ASN.2014020190.
   PubMed Web of Science ®Google Scholar
• Benigni A, Morigi M, Rizzo P, et al. Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol. 2011;179:628–638. doi:10.1016/j.ajpath.2011.04.003.
   PubMed Web of Science ®Google Scholar
• Lichtnekert J, Kaverina NV, Eng DG, et al. Renin-angiotensin-aldosterone system inhibition increases podocyte derivation from cells of renin lineage. J Am Soc Nephrol. 2016 [Epub ahead of print].
   PubMedGoogle Scholar
• Zhang J, Pippin JW, Krofft RD, et al. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS. Am J Physiol Renal Physiol. 2013;304:F1375–89. doi:10.1152/ajprenal.00020.2013.
   PubMed Web of Science ®Google Scholar
• Migliorini A, Angelotti ML, Mulay SR, et al. The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration. Am J Pathol. 2013;183:431–440. doi:10.1016/j.ajpath.2013.04.017.
   PubMed Web of Science ®Google Scholar
• Peired A, Angelotti ML, Ronconi E, et al. Proteinuria impairs podocyte regeneration by sequestering retinoic acid. J Am Soc Nephrol. 2013;24:1756–1768. doi:10.1681/ASN.2012090950.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Romagnani P, Mantovani A. Pathomechanisms: homeostatic chemokines in health, tissue regeneration, and progressive diseases. Trends Mol Med. 2014;20:154–165. doi:10.1016/j.molmed.2013.12.002.
   PubMed Web of Science ®Google Scholar
• Lasagni L, Lazzeri E, Shankland SJ, et al. Podocyte mitosis - a catastrophe. Curr Mol Med. 2013;13:13–23.
   PubMed Web of Science ®Google Scholar
• Sallustio F, Serino G, Costantino V, et al. miR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells. PLoS One. 2013;8:e68296. doi:10.1371/journal.pone.0068296.
   PubMed Web of Science ®Google Scholar
• Bussolati B, Moggio A, Collino F, et al. Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance. Am J Physiol Renal Physiol. 2012;302:F116–F128. doi:10.1152/ajprenal.00184.2011.
   Google Scholar
• Gebeshuber CA, Kornauth C, Dong L, et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med. 2013;19:481–487. doi:10.1038/nm.3142.
   PubMed Web of Science ®Google Scholar
• Guo N, Guo J, Su D. MicroRNA-206 and its down-regulation of Wilms’Tumor-1 dictate podocyte health in adriamycin-induced nephropathy. Ren Fail. 2016;38:989–995 [Epub ahead of print]. doi:10.3109/0886022X.2016.1165119.
   PubMed Web of Science ®Google Scholar
• Remuzzi A, Sangalli F, Macconi D, et al. Regression of renal disease by angiotensin II antagonism is caused by regeneration of kidney vasculature. J Am Soc Nephrol. 2016;27:699–705. doi:10.1681/ASN.2014100971.
   PubMed Web of Science ®Google Scholar
• Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7:189–200. doi:10.1038/nrneph.2011.16.
   PubMed Web of Science ®Google Scholar
• Zuk A, Bonventre JV. Acute kidney injury. Annu Rev Med. 2016;67:293–307. doi:10.1146/annurev-med-050214-013407.
   PubMed Web of Science ®Google Scholar
• Humphreys BD, Valerius MT, Kobayashi A, et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell. 2008;2:284–291. doi:10.1016/j.stem.2008.01.014.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756–766. doi:10.1016/S0140-6736(11)61454-2.
   PubMed Web of Science ®Google Scholar
• Rinkevich Y, Montoro DT, Contreras-Trujillo H, et al. In vivo clonal analysisreveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep. 2014;7:1270–1283. doi:10.1016/j.celrep.2014.05.022.
   PubMed Web of Science ®Google Scholar
• Lindgren D, Boström A-K, Nilsson K, et al. Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol. 2011;178:828–837. doi:10.1016/j.ajpath.2010.10.026.
   PubMed Web of Science ®Google Scholar
• Smeets B, Boor P, Dijkman H, et al. Proximal tubular cells contain a phenotypically distinct, scatteredcell population involved in tubular regeneration. J Pathol. 2013;229:645–659. doi:10.1002/path.4125.
   PubMed Web of Science ®Google Scholar
• Hansson J, Hultenby K, Cramnert C, et al. Evidence for a morphologically distinct and functionally robust cell type in the proximal tubules of human kidney. Hum Pathol. 2014;45:382–393. doi:10.1016/j.humpath.2013.10.003.
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121:4210–4221. doi:10.1172/JCI57873.
   PubMed Web of Science ®Google Scholar
• Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int. 2007;72:151–156. doi:10.1038/sj.ki.5002580.
   PubMed Web of Science ®Google Scholar
• Kramann R, Tanaka M, Humphreys BD. Fluorescence microangiography for quantitative assessment of peritubular capillarychanges after AKI in mice. J Am Soc Nephrol. 2014;25:1924–1931. doi:10.1681/ASN.2013101121.
   PubMed Web of Science ®Google Scholar
• Yang L, Besschetnova TY, Brooks CR, et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med. 2010;16:535–543. doi:10.1038/nm1110-1167.
   PubMed Web of Science ®Google Scholar
• Kim J, Seok YM, Jung K-J, et al. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am J Physiol Renal Physiol. 2009;297:F461–F470. doi:10.1152/ajprenal.90735.2008.
   PubMed Web of Science ®Google Scholar
• Basile DP, Leonard EC, Beal AG, et al. Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. Am J Physiol Renal Physiol. 2012;302:F1494–F1502. doi:10.1152/ajprenal.00691.2011.
   PubMed Web of Science ®Google Scholar
• Kapitsinou PP, Jaffe J, Michael M, et al. Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury. Am J Physiol Renal Physiol. 2012;302:F1172–79. doi:10.1152/ajprenal.00667.2011.
   PubMed Web of Science ®Google Scholar
• Leonard EC, Friedrich JL, Basile DP. VEGF-121 preserves renal microvessel structureand ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol. 2008;295:F1648–57. doi:10.1152/ajprenal.00099.2008.
   PubMed Web of Science ®Google Scholar
• Liu M, Reddy NM, Higbee EM, et al. The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice. Kidney Int. 2014;85:134–141. doi:10.1038/ki.2013.357.
   PubMed Web of Science ®Google Scholar
• Wu J, Liu X, Fan J, et al. Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway. Toxicology. 2014;318:22–31. doi:10.1016/j.tox.2014.01.008.
   PubMed Web of Science ®Google Scholar
• Lee S, Huen S, Nishio H, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011;22:317–326. doi:10.1681/ASN.2009060615.
   PubMed Web of Science ®Google Scholar
• Zhang M-Z, Yao B, Yang S, et al. CSF-1 signaling mediates recovery fromacute kidney injury. J Clin Invest. 2012;122:4519–4532. doi:10.1172/JCI57313.
   PubMed Web of Science ®Google Scholar
• Anders H-J, Schaefer L. Beyond tissue injury damage-associated molecular patterns, toll like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol. 2014;25:1387–1400. doi:10.1681/ASN.2014010117.
   PubMed Web of Science ®Google Scholar
• Kulkarni OP, Hartter I, Mulay SR, et al. Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J AmSoc Nephrol. 2014;25:978–989. doi:10.1681/ASN.2013050528.
   PubMed Web of Science ®Google Scholar
• Barry ER, Morikawa T, Butler BL, et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature. 2013;493:106–110. doi:10.1038/nature11818.
   PubMed Web of Science ®Google Scholar
• Grijalva JL, Huizenga M, Mueller K, et al. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014;307:G196–G204. doi:10.1152/ajpgi.00144.2014.
   Google Scholar
• Xu J, Li PX, Wu J, et al. Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector. Clin Sci. 2016;130:349–363. doi:10.1042/CS20150385.
   PubMed Web of Science ®Google Scholar
• Szeto SG, Narimatsu M, Lu M, et al. YAP/TAZ are mechanoregulators of TGF-β-smad signaling and renal fibrogenesis. J Am Soc Nephrol. 2016 [Epub ahead of print].
   Google Scholar
• Sirin Y, Susztak K. Notch in the kidney: development and disease. J Pathol. 2012;226:394–403. doi:10.1002/path.2967.
   PubMed Web of Science ®Google Scholar
• Bielesz B, Sirin Y, Si H, et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.J. Clin Invest. 2010;120:4040–4054.
   Google Scholar
• Kramer J, Schwanbeck R, Pagel H, et al. Inhibition of Notch signaling ameliorates acute kidney failure and downregulates platelet-derived growth factor receptor β in the mouse model. Cells Tissues Organs. 2016;201:109–117. doi:10.1159/000442463.
   PubMed Web of Science ®Google Scholar
• Price PM, Safirstein RL, Megyesi J. The cell cycle and acute kidney injury. Kidney Int. 2009;76:604–613. doi:10.1038/ki.2009.290.
   PubMed Web of Science ®Google Scholar
• Megyesi J, Safirstein RL, Price PM. Inductionof p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest. 1998;101:777–782. doi:10.1172/JCI2325.
   PubMed Web of Science ®Google Scholar
• Di Rocco DP, Bisi J, Roberts P, et al. CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury. Am J Physiol Renal Physiol. 2014;306:F379– 88. doi:10.1152/ajprenal.00675.2013.
   Google Scholar
• Kellum JA, Chawla LS. Cell-cycle arrest and acute kidney injury: the light and the dark sides. Nephrol Dial Transplant. 2016 Jan;31(1):16–22. doi:10.1093/ndt/gfv130.
   PubMed Web of Science ®Google Scholar
• Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 2012;82:516–524. doi:10.1038/ki.2012.208.
   PubMed Web of Science ®Google Scholar
• Lovisa S, LeBleu VS, Tampe B, et al. Epithelial-to-mesenchymal transition induces cell-cycle arrest and parenchymal damage in renal fibrosis. Nat Med. 2015;21:998–1009. doi:10.1038/nm.3902.
   PubMed Web of Science ®Google Scholar
• Cianciolo Cosentino C, Skrypnyk NI, Brilli LL, et al. Histone deacetylase inhibitor enhances recovery after AKI. J Am Soc Nephrol. 2013;24:943–953. doi:10.1681/ASN.2012111055.
   PubMed Web of Science ®Google Scholar
• Tang J, Liu N, Tolbert E, et al. Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury. Am J Pathol. 2013;183:160–172. doi:10.1016/j.ajpath.2013.04.005.
   PubMed Web of Science ®Google Scholar
• Cuppage FE, Tate A. Repair of the nephron following injury with mercuric chloride. Am J Pathol. 1967;51:405–429.
   PubMed Web of Science ®Google Scholar
• De Groh ED, Swanhart LM, Cosentino CC, et al. Inhibition of histone deacetylase expands the renal progenitor cell population. J Am Soc Nephrol. 2010;21:794–802. doi:10.1681/ASN.2009080851.
   PubMed Web of Science ®Google Scholar
• Van Beneden K, Geers C, Pauwels M, et al. Valproic acid attenuates proteinuria and kidney injury. J Am Soc Nephrol. 2011;22:1863–1875. doi:10.1681/ASN.2010111196.
   PubMed Web of Science ®Google Scholar
• Advani A, Huang Q, Thai K, et al. Long-term administration of the histone deacetylase inhibitor vorinostat attenuates renal injury in experimental diabetes through an endothelial nitric oxide synthase dependent mechanism. Am J Pathol. 2011;178:2205–2214. doi:10.1016/j.ajpath.2011.01.044.
   PubMed Web of Science ®Google Scholar
• Pang M, Ma L, Liu N, et al. Histone deacetylase 1/2 mediates proliferation of renal interstitial fibroblasts and expression of cell cycle proteins. J Cell Biochem. 2011;112:2138–2148. doi:10.1002/jcb.23135.
   PubMed Web of Science ®Google Scholar
• Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25. doi:10.1186/cc12734.
   PubMed Web of Science ®Google Scholar